Cumberland Pharmaceuticals (CPIX) Income from Non-Controlling Interests: 2009-2025
Historic Income from Non-Controlling Interests for Cumberland Pharmaceuticals (CPIX) over the last 17 years, with Sep 2025 value amounting to -$8,282.
- Cumberland Pharmaceuticals' Income from Non-Controlling Interests fell 216.45% to -$8,282 in Q3 2025 from the same period last year, while for Sep 2025 it was -$9,456, marking a year-over-year decrease of 135.96%. This contributed to the annual value of $36,055 for FY2024, which is 170.08% up from last year.
- Latest data reveals that Cumberland Pharmaceuticals reported Income from Non-Controlling Interests of -$8,282 as of Q3 2025, which was down 249.68% from $5,533 recorded in Q2 2025.
- Cumberland Pharmaceuticals' Income from Non-Controlling Interests' 5-year high stood at $43,791 during Q1 2024, with a 5-year trough of -$36,561 in Q4 2021.
- Over the past 3 years, Cumberland Pharmaceuticals' median Income from Non-Controlling Interests value was -$8,282 (recorded in 2025), while the average stood at -$2,457.
- In the last 5 years, Cumberland Pharmaceuticals' Income from Non-Controlling Interests slumped by 473.01% in 2022 and then surged by 320.08% in 2024.
- Over the past 5 years, Cumberland Pharmaceuticals' Income from Non-Controlling Interests (Quarterly) stood at -$36,561 in 2021, then skyrocketed by 48.07% to -$18,985 in 2022, then surged by 60.07% to -$7,581 in 2023, then soared by 128.72% to $2,177 in 2024, then slumped by 216.45% to -$8,282 in 2025.
- Its Income from Non-Controlling Interests was -$8,282 in Q3 2025, compared to $5,533 in Q2 2025 and -$8,884 in Q1 2025.